SPARQL
Query
Update
Search
Quick
Advanced
Co-occurrence
RelFinder
About
Sources
Admin
System Info
Repository Management
Search Configuration
Sources
16301595
Source:
http://linkedlifedata.com/resource/pubmed/id/16301595
Search
Subject
(
56
)
Predicate
Object
All
Download in:
JSON
RDF
N3/Turtle
N-Triples
Switch to
Custom View
Named Graph
All
UniProt
NCBIGene
DrugBank
ClinicalTrials
UMLS
PubMed
Mappings
MentionedEntities
Language
All
English
Español
Português
Français
Deutsch
Русский
日本語
Български
Inference
Explicit and implicit
Explicit only
Implicit only
Statements in which the resource exists as a subject.
Predicate
Object
rdf:type
pubmed:Citation
lifeskim:mentions
umls-concept:C0030705
,
umls-concept:C0205179
,
umls-concept:C0205390
,
umls-concept:C0280100
,
umls-concept:C0332174
,
umls-concept:C2348461
,
umls-concept:C2603343
pubmed:issue
36
pubmed:dateCreated
2005-12-19
pubmed:abstractText
To evaluate the safety and maximum-tolerated dose (MTD) of weekly patupilone, a natural epothilone B, in patients with advanced solid tumors.
pubmed:commentsCorrections
http://linkedlifedata.com/resource/pubmed/commentcorrection/16301595-16301592
pubmed:language
eng
pubmed:journal
http://linkedlifedata.com/resource/pubmed/journal/8309333
pubmed:citationSubset
IM
pubmed:chemical
http://linkedlifedata.com/resource/pubmed/chemical/Antineoplastic Agents
,
http://linkedlifedata.com/resource/pubmed/chemical/Epothilones
,
http://linkedlifedata.com/resource/pubmed/chemical/epothilone B
pubmed:status
MEDLINE
pubmed:month
Dec
pubmed:issn
0732-183X
pubmed:author
pubmed-author:ChenTianlingT
,
pubmed-author:HoYu-YunYY
,
pubmed-author:HsuChyi-HungCH
,
pubmed-author:HubertMartineM
,
pubmed-author:OzaAmit MAM
,
pubmed-author:RothermelJohnJ
,
pubmed-author:RubinEric HEH
,
pubmed-author:TesfayeFissehaF
pubmed:issnType
Print
pubmed:day
20
pubmed:volume
23
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
9120-9
pubmed:dateRevised
2006-11-15
pubmed:meshHeading
pubmed-meshheading:16301595-Adult
,
pubmed-meshheading:16301595-Aged
,
pubmed-meshheading:16301595-Antineoplastic Agents
,
pubmed-meshheading:16301595-Drug Administration Schedule
,
pubmed-meshheading:16301595-Epothilones
,
pubmed-meshheading:16301595-Female
,
pubmed-meshheading:16301595-Half-Life
,
pubmed-meshheading:16301595-Humans
,
pubmed-meshheading:16301595-Infusions, Intravenous
,
pubmed-meshheading:16301595-Male
,
pubmed-meshheading:16301595-Maximum Tolerated Dose
,
pubmed-meshheading:16301595-Middle Aged
,
pubmed-meshheading:16301595-Neoplasms
pubmed:year
2005
pubmed:articleTitle
Phase I dose-finding study of weekly single-agent patupilone in patients with advanced solid tumors.
pubmed:affiliation
Cancer Institute of New Jersey, New Brunswick, NJ 08901, USA. ehrubin@umdnj.edu
pubmed:publicationType
Journal Article
,
Research Support, Non-U.S. Gov't
,
Multicenter Study
,
Clinical Trial, Phase I